C. de Mendoza

发表

Prevalence of X4 tropic HIV‐1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

E. Poveda, J. Benito, V. Soriano, 2007, Journal of medical virology.

X4 tropic viruses are on the rise in recent HIV-1 seroconverters in Spain

J. Eiros, V. Soriano, A. Aguilera, 2014, AIDS.

Improvement in the determination of HIV‐1 tropism using the V3 gene sequence and a combination of bioinformatic tools

Natalia Chueca, Federico García, E. Poveda, 2009, Journal of medical virology.

Primary resistance to maraviroc in a large set of R5-V3 viral sequences from HIV-1-infected patients.

E. Poveda, V. Soriano, E. Seclén, 2010, The Journal of antimicrobial chemotherapy.

Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemia.

E. Poveda, V. Soriano, E. Seclén, 2010, The Journal of antimicrobial chemotherapy.

Decline and Changing Profile of Hepatitis Delta among Injection Drug users in Spain

V. Soriano, A. Aguilera, J. Peña, 2018, Antiviral therapy.

Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.

V. Soriano, C. de Mendoza, Rocío Sierra-Enguita, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS.

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

E. Poveda, V. Soriano, J. Blanco, 2010, AIDS.

Gene therapy for HIV infection

V. Soriano, C. de Mendoza, P. Barreiro, 2015, Expert opinion on biological therapy.

New hepatitis C therapies for special patient populations

V. Soriano, I. Esposito, J. Peña, 2016, Expert opinion on pharmacotherapy.

Emerging Challenges in Managing Hepatitis B in HIV Patients

V. Soriano, I. Esposito, J. Peña, 2015, Current HIV/AIDS Reports.

Predicted Effect of Direct Acting Antivirals in the Current HIV–HCV-Coinfected Population in Spain

E. Poveda, V. Soriano, C. de Mendoza, 2011, Antiviral therapy.

Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.

M. Maciá, V. Soriano, C. de Mendoza, 2019, AIDS.

Phenotypic impact of resistance mutations on etravirine susceptibility in HIV patients with prior failure to nonnucleoside analogues

E. Poveda, V. Soriano, J. Villacian, 2008, AIDS.

Resistance to integrase inhibitors.

V. Soriano, C. de Mendoza, C. Garrido, 2007, Journal of HIV therapy.

Comparison of Three Different Commercial Methods for Measuring Plasma Viraemia in Patients Infected with Non-B HIV-1 Subtypes

Á. Holguín, V. Soriano, C. de Mendoza, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Raltegravir and etravirine are active against HIV type 1 group O.

E. Poveda, V. Soriano, V. Briz, 2009, AIDS research and human retroviruses.

The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy

D. Pillay, G. Poggensee, B. Masquelier, 2006, AIDS.

Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial.

V. Soriano, C. de Mendoza, J. González-lahoz, 2007, The Journal of antimicrobial chemotherapy.

Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters

E. Poveda, V. Soriano, L. Stuyver, 2008, Journal of Acquired Immune Deficiency Syndromes.

Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.

V. Soriano, J. Hackett, C. de Mendoza, 2007, Journal of virological methods.

Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.

L. Sandvik, S. G. Gundersen, A. Johannessen, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Liver Fibrosis Progression despite HCV Cure with Antiviral Therapy in HIV–HCV-Coinfected Patients

V. Soriano, C. de Mendoza, P. Labarga, 2015, Antiviral therapy.

Dual antiviral therapy for HIV and hepatitis C – drug interactions and side effects

V. Soriano, I. Esposito, J. Peña, 2015, Expert opinion on drug safety.

Hypoglycemia in a diabetic patient during hepatitis C therapy

V. Soriano, C. de Mendoza, P. Barreiro, 2016, Hepatology.

Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements.

V. Soriano, C. de Mendoza, J. González-lahoz, 2008, The Journal of antimicrobial chemotherapy.

Treatment and prevention of HIV infection with long-acting antiretrovirals

V. Soriano, C. de Mendoza, A. Arias, 2018, Expert review of clinical pharmacology.

The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America.

V. Soriano, A. Aguilera, F. Gómez-Gallego, 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Benefits of hepatitis C cure with antivirals: why test and treat?

V. Cuervas-Mons, C. de Mendoza, A. Arias, 2019, Future microbiology.

Hepatitis C Cure with Antiviral Therapy – Benefits beyond the Liver

V. Soriano, I. Esposito, C. de Mendoza, 2015, Antiviral therapy.

Long-Term Survival and Liver-Related Events after Pegylated Interferon/Ribavirin Therapy in HIV-Infected Patients with Chronic Hepatitis C

V. Soriano, C. de Mendoza, P. Labarga, 2015, Antiviral therapy.

Hepatitis C therapy with HCV NS5B polymerase inhibitors

E. Poveda, V. Soriano, C. de Mendoza, 2013, Expert opinion on pharmacotherapy.

Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.

V. Cuervas-Mons, C. de Mendoza, A. Arias, 2016, Transplantation proceedings.

Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

J. Ramos-Rincón, V. Soriano, C. de Mendoza, 2022, Hepatology International.

Towards hepatitis C eradication from the HIV-infected population.

V. Soriano, C. de Mendoza, P. Labarga, 2014, Antiviral research.

HTLV-1 infection and disease in Spain.

S. Sauleda, J. Eiros, V. Soriano, 2017, AIDS.

Treatment of hepatitis C with new fixed dose combinations

V. Soriano, J. Peña, C. de Mendoza, 2017, Expert opinion on pharmacotherapy.

Evaluation of sofosbuvir, velpatasvir plus voxilaprevir as fixed-dose co-formulation for treating hepatitis C

V. Soriano, J. Peña, C. de Mendoza, 2017, Expert opinion on drug metabolism & toxicology.

Impact of ITPA Gene Polymorphisms on the Risk of Ribavirin-Induced Haemolytic Anaemia using Interferon-Free Antivirals for Chronic Hepatitis C

V. Cuervas-Mons, V. Soriano, I. Esposito, 2017, Antiviral therapy.

Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana

J. Fobil, V. Soriano, C. de Mendoza, 2019, Therapeutic advances in infectious disease.

Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection

A. Royuela, V. Cuervas-Mons, C. de Mendoza, 2018, AIDS.

Rilpivirine: a next-generation non-nucleoside analogue for the treatment of HIV infection

V. Soriano, C. de Mendoza, J. V. Fernández-Montero, 2012, Expert opinion on pharmacotherapy.

Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

B. Rodés, C. Toro, E. Poveda, 2003, AIDS patient care and STDs.

Drug interactions with new hepatitis C oral drugs

V. Soriano, I. Esposito, J. Peña, 2015, Expert opinion on drug metabolism & toxicology.

Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.

V. Soriano, C. de Mendoza, A. Corral, 2005, AIDS patient care and STDs.

Third wave of COVID-19 in Madrid, Spain

V. Soriano, F. Gómez-Gallego, C. de Mendoza, 2021, International Journal of Infectious Diseases.

COVID-19 Comes 40 Years After AIDS - Any Lesson?

J. Eiros, V. Soriano, C. de Mendoza, 2020, AIDS Reviews.

Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry

G. Ruiz-Irastorza, M. Martinez-Urbistondo, A. Royuela, 2021, Journal of clinical medicine.

Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

V. Soriano, C. de Mendoza, A. Corral, 2009, Antimicrobial Agents and Chemotherapy.

Bacterial infections in patients hospitalized with COVID-19

M. J. Fresnadillo Martínez, M. Martinez-Urbistondo, A. Royuela, 2021, Internal and Emergency Medicine.

Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals

V. Soriano, C. de Mendoza, G. Reina, 2019, Therapeutic advances in infectious disease.

Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).

C. de Mendoza, J. Blanco, M. Pérez-Elías, 2011, Antiviral research.

Rate and Predictors of Treatment Failure to All-Oral HCV Regimens outside Clinical Trials

V. Cuervas-Mons, V. Soriano, A. Aguilera, 2016, Antiviral therapy.

High Serum HCV RNA in Chronic Hepatitis C Patients Coinfected with HIV despite Successful Antiretroviral Therapy

V. Soriano, J. Peña, C. de Mendoza, 2016, Antiviral therapy.

Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

J. Ramos-Rincón, V. Soriano, C. de Mendoza, 2022, Hepatology International.

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy.

E. Poveda, V. Soriano, C. de Mendoza, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The Role of Hepatitis C Virus (HCV) in Mitochondrial Dna Damage in HIV/HCV-Coinfected Individuals

V. Soriano, C. de Mendoza, 2005, Antiviral therapy.

Multicenter evaluation of the NucliSens EasyQ HIV-1 v1.1 assay for the quantitative detection of HIV-1 RNA in plasma.

V. Ferré, V. Soriano, M. Segondy, 2005, Journal of virological methods.

Correlation between Human Immunodeficiency Virus Type 1 (HIV-1) RNA Measurements Obtained with Dried Blood Spots and Those Obtained with Plasma by Use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV Load Tests

V. Soriano, C. de Mendoza, A. Corral, 2009, Journal of Clinical Microbiology.

Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.

F. Antunes, V. Soriano, C. de Mendoza, 2008, The Journal of antimicrobial chemotherapy.

False positives for HIV using commercial viral load quantification assays.

Á. Holguín, V. Soriano, C. de Mendoza, 1998, AIDS.

Plasma raltegravir exposure influences the antiviral activity and selection of resistance mutations.

V. Soriano, E. Ribera, C. de Mendoza, 2012, AIDS research and human retroviruses.

Advances in treating drug-resistant hepatitis B virus in HIV-infected patients

V. Soriano, J. Peña, C. de Mendoza, 2015, Expert opinion on pharmacotherapy.

Progression to Advanced Liver Fibrosis in HIV–HCV-Coinfected Patients and Prioritization of New Hepatitis C Therapies

V. Soriano, C. de Mendoza, Rocío Sierra-Enguita, 2014, Antiviral therapy.

Management and treatment of chronic hepatitis B in HIV-positive patients

V. Soriano, C. de Mendoza, P. Labarga, 2014, Annals of medicine.

Comparison of HIV-1 RNA Measurements Obtained by Using Plasma and Dried Blood Spots in the Automated Abbott Real-Time Viral Load Assay

N. Parkin, V. Soriano, C. de Mendoza, 2011, Journal of Clinical Microbiology.

Need to Face Liver Cirrhosis after HCV Cure with Antivirals

V. Soriano, C. de Mendoza, A. Arias, 2017, EBioMedicine.

Evaluation of the Abbott LCx Quantitative Assay for Measurement of Human Immunodeficiency Virus RNA in Plasma

V. Soriano, J. Alcamí, D. Folgueira, 2002, Journal of Clinical Microbiology.

Reductions in Stavudine Dose Might Ameliorate Mitochondrial-Associated Complications Without Compromising Antiviral Activity

V. Soriano, C. de Mendoza, J. González-lahoz, 2005, HIV clinical trials.

Minority HIV mutation detection in dried blood spots indicates high specimen integrity and reveals hidden archived drug resistance.

W. Heneine, C. de Mendoza, A. Corral, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4°C

C. de Mendoza, N. Zahonero, C. Garrido, 2008, The Journal of antimicrobial chemotherapy.

Changing rate of non-B subtypes and coinfection with hepatitis B/C viruses in newly diagnosed HIV type 1 individuals in Spain.

V. Soriano, J. del Romero, C. de Mendoza, 2011, AIDS research and human retroviruses.

Mechanisms involved in CD4 cell gains in HIV-infected patients switched to raltegravir

J. Benito, V. Soriano, C. de Mendoza, 2012, AIDS.

Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades

J. Ramos-Rincón, V. Soriano, F. Gómez-Gallego, 2021, AIDS.

Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals.

V. Soriano, J. del Romero, C. de Mendoza, 2009, AIDS research and human retroviruses.

Short article: Hepatitis delta in patients with resolved hepatitis B virus infection

V. Soriano, A. Aguilera, C. de Mendoza, 2018, European journal of gastroenterology & hepatology.

Ultra-long-acting (XLA) antivirals for chronic viral hepatitis

H. Gendelman, V. Soriano, C. de Mendoza, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients

W. Heneine, C. de Mendoza, A. Corral, 2007, AIDS.

Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.

V. Soriano, C. de Mendoza, J. González-lahoz, 2004, AIDS research and human retroviruses.

Very Late HCV Relapse following Triple Therapy for Hepatitis C

V. Soriano, A. Aguilera, C. de Mendoza, 2014, Antiviral therapy.

Very Late Relapse after Discontinuation of Antiviral Therapy for Chronic Hepatitis C

E. Poveda, V. Soriano, C. de Mendoza, 2013, Antiviral therapy.

Evolution of T-cell Responses to Hepatitis C Virus (HCV) during Pegylated Interferon plus Ribavirin treatment in HCV-Monoinfected and in HCV/HIV-Coinfected Patients

J. Benito, V. Soriano, C. de Mendoza, 2007, Antiviral therapy.

Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance

V. Soriano, C. de Mendoza, A. Corral, 2008, AIDS.

Liver Fibrosis Progression in HIV–HCV-Coinfected Patients Treated with Distinct Antiretroviral Drugs and Impact of Pegylated Interferon/Ribavirin Therapy

V. Soriano, C. de Mendoza, P. Labarga, 2014, Antiviral therapy.

Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy

V. Soriano, M. Leal, J. del Romero, 2006, Journal of acquired immune deficiency syndromes.

Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in Spain

V. Soriano, C. de Mendoza, Rubén González-Crespo, 2021, International Journal of Infectious Diseases.

Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain

V. Cuervas-Mons, C. de Mendoza, A. Arias, 2021, Medicine.

Main differences between the first and second waves of COVID-19 in Madrid, Spain

V. Soriano, F. Gómez-Gallego, C. de Mendoza, 2021, International Journal of Infectious Diseases.

Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.

V. Soriano, C. de Mendoza, J. González-lahoz, 2007, AIDS research and human retroviruses.

New antivirals for the treatment of chronic hepatitis B

V. Soriano, J. Peña, C. de Mendoza, 2017, Expert opinion on investigational drugs.

Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations

V. Soriano, C. de Mendoza, A. Corral, 2004, AIDS.

Natural Polymorphisms Associated with Resistance to New Antivirals against HCV in Newly Diagnosed HIV–HCV-Coinfected Patients

E. Poveda, V. Soriano, J. del Romero, 2011, Antiviral therapy.

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

V. Soriano, C. de Mendoza, J. González-lahoz, 2006, AIDS research and human retroviruses.

Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir.

V. Soriano, C. de Mendoza, P. Labarga, 2002, AIDS.

Integrase variability and susceptibility to HIV integrase inhibitors: impact of subtypes, antiretroviral experience and duration of HIV infection.

V. Soriano, A. Geretti, C. de Mendoza, 2010, The Journal of antimicrobial chemotherapy.

Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

V. Soriano, C. de Mendoza, P. Domingo, 2004, AIDS reviews.

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

J. Martinez-Picado, J. Blanco, L. Menéndez-Arias, 2012, Retrovirology.

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2006, Journal of acquired immune deficiency syndromes.

Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals.

V. Soriano, C. de Mendoza, A. Corral, 2004, Journal of virological methods.

Clinical Validation of Saquinavir/Ritonavir Genotypic Resistance Score in Protease-Inhibitor-Experienced Patients

V. Calvez, C. Katlama, V. Soriano, 2007, Antiviral therapy.

Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.

V. Soriano, C. de Mendoza, J. González-lahoz, 2002, International journal of antimicrobial agents.

Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

E. Paxinos, V. Soriano, C. de Mendoza, 2004, Journal of Clinical Microbiology.

Prevention and management of treatment failure to new oral hepatitis C drugs

V. Soriano, J. Peña, C. de Mendoza, 2016, Expert opinion on pharmacotherapy.

Baseline NS5A resistance associated substitutions may impair DAA response in real‐world hepatitis C patients

V. Cuervas-Mons, C. de Mendoza, A. Arias, 2018, Journal of medical virology.

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

E. Poveda, V. Soriano, C. de Mendoza, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients.

V. Soriano, C. de Mendoza, A. Corral, 2007, AIDS research and human retroviruses.

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral‐experienced HIV‐infected patients

J. Martinez-Picado, B. Rodés, V. Soriano, 2005, Journal of medical virology.

Hepatitis delta in patients hospitalized in Spain (1997–2018)

J. Ramos-Rincón, V. Soriano, A. Aguilera, 2021, AIDS.

Emerging viral infections‑-a potential threat for blood supply in the 21st century.

J. Batlle, V. Soriano, C. Altisent, 2012, AIDS reviews.

Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in Spain.

E. Poveda, V. Soriano, C. de Mendoza, 2013, The American journal of tropical medicine and hygiene.

Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain.

V. Soriano, J. Eiros, J. Torre-Cisneros, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children

V. Soriano, M. Muñoz-Fernandez, C. de Mendoza, 2007, BMC infectious diseases.

Spontaneous hepatitis C virus clearance in one HIV patient with chronic hepatitis C bearing IL28B-CC alleles and detectable plasma HIV-RNA.

V. Cuervas-Mons, C. de Mendoza, L. Benítez-Gutiérrez, 2014, AIDS.

Spontaneous hepatitis C virus clearance in HIV patients with chronic hepatitis C bearing IL28B-CC alleles using antiretroviral therapy

V. Soriano, C. de Mendoza, Rocío Sierra-Enguita, 2014, AIDS.

Tough requirements for new antiretroviral drugs.

V. Soriano, C. de Mendoza, 2020, The lancet. HIV.

Long-acting antiretroviral therapy

V. Soriano, C. de Mendoza, P. Barreiro, 2020, Nature Materials.

Molecular and epidemiological characteristics of blood‐borne virus infections among recent immigrants in Spain

B. Rodés, C. Toro, V. Soriano, 2006, Journal of medical virology.

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

V. Soriano, C. Briones, A. Álvarez, 2000, Journal of acquired immune deficiency syndromes.

Pharmacogenetics of antiretroviral therapy

Pablo Barreiro, V. Soriano, C. de Mendoza, 2014, Expert opinion on drug metabolism & toxicology.

Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients

V. Soriano, C. de Mendoza, S. Rodríguez-Nóvoa, 2007, Expert opinion on pharmacotherapy.

Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses.

V. Soriano, P. Torres, C. de Mendoza, 2012, AIDS research and human retroviruses.

Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.

Soo-Yon Rhee, Robert W Shafer, Philip L. Tzou, 2020, The Journal of infectious diseases.

Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain

G. Marcaida, J. Niubó, V. Cuervas-Mons, 2019, The Journal of antimicrobial chemotherapy.

High rate of resistance to antiretroviral drugs among HIV-infected prison inmates.

V. Soriano, C. de Mendoza, A. Corral, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Hospital admissions in individuals with HTLV-1 infection in Spain.

J. Eiros, V. Soriano, A. Aguilera, 2020, AIDS.

Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes.

C. Vidal, J. Blanco, V. Soriano, 2013, The Journal of antimicrobial chemotherapy.

Coronavirus and other airborne agents with pandemic potential

M. Artacho, V. Soriano, C. de Mendoza, 2020, Current Opinion in Environmental Science & Health.

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2005, The Journal of infectious diseases.

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

O. Pybus, A. Wensing, K. Korn, 2009, Retrovirology.

Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance.

L. Ruiz, V. Soriano, J. Eiros, 2007, The Journal of antimicrobial chemotherapy.

Monitoring the response to antiretroviral therapy in HIV‐1 group O infected patients using two new RT‐PCR assays

V. Soriano, J. Castilla, C. de Mendoza, 2001, Journal of medical virology.

HIV type 2 epidemic in Spain: challenges and missing opportunities

V. Soriano, C. de Mendoza, E. Caballero, 2017, AIDS.

Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.

V. Soriano, J. del Romero, C. de Mendoza, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of drug levels and baseline genotype and phenotype on the virologic response to amprenavir/ritonavir-based salvage regimens.

V. Soriano, C. de Mendoza, J. González-lahoz, 2004, AIDS patient care and STDs.

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.

N. Parkin, J. Bremer, R. Schuurman, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Burden of Neglected HIV-2 and HTLV-1 Infections in Spain.

V. Soriano, A. Aguilera, C. de Mendoza, 2015, AIDS reviews.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Advances in hepatitis B therapeutics

V. Soriano, S. Kottilil, C. de Mendoza, 2020, Therapeutic advances in infectious disease.

Resistance to HIV protease inhibitors: mechanisms and clinical consequences.

V. Soriano, C. de Mendoza, 2004, Current drug metabolism.

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

B. Rodés, V. Soriano, C. de Mendoza, 2002, AIDS research and human retroviruses.

HTLV infection in HCV-antibody positive patients in Spain.

E. Poveda, V. Soriano, Araceli Hernández, 2017, AIDS research and human retroviruses.

Development of tropical spastic paraparesis in human T-lymphotropic virus type 1 carriers is influenced by interleukin 28B gene polymorphisms.

V. Soriano, J. Eiros, A. Aguilera, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HTLV testing of solid organ transplant donors

J. Miro, E. Poveda, S. Sauleda, 2019, Clinical transplantation.

HTLV-1 infection in solid organ transplant donors and recipients in Spain

V. Soriano, A. Aguilera, C. de Mendoza, 2019, BMC Infectious Diseases.

Antiviral effect of raltegravir on HTLV-1 carriers.

V. Soriano, C. de Mendoza, T. Bar-Magen, 2012, The Journal of antimicrobial chemotherapy.

Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

V. Soriano, G. Marcaida, Araceli Hernández, 2012, Virology Journal.

Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain.

V. Soriano, L. Alcântara, J. Eiros, 2014, AIDS research and human retroviruses.

Hepatic Decompensation with Sofosbuvir plus Simeprevir in a Patient with Child–Pugh B Compensated Cirrhosis

V. Soriano, J. Peña, C. de Mendoza, 2016, Antiviral therapy.

Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes

Natalia Chueca, E. Poveda, V. Soriano, 2008, Journal of Clinical Microbiology.

Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

J. Benito, V. Soriano, C. de Mendoza, 2007, AIDS.

Is SARS-CoV-2 the only cause of long-COVID?

C. de Mendoza, I. Pintos-Pascual, A. Treviño, 2022, AIDS reviews.

HTLV infection among foreign pregnant women living in Spain.

V. Soriano, G. Marcaida, J. Eiros, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

J. Miro, E. Poveda, S. Sauleda, 2019, Open forum infectious diseases.

HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)

V. Soriano, C. de Mendoza, G. González-Alcaide, 2016, Revista do Instituto de Medicina Tropical de Sao Paulo.

HIV-2 and HTLV-1 infections in Spain, a non-endemic region.

V. Soriano, A. Aguilera, C. de Mendoza, 2014, AIDS reviews.

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

E. Poveda, J. Eiros, V. Soriano, 2014, The Journal of antimicrobial chemotherapy.

Drug resistance mutations in patients infected with HIV-2 living in Spain.

V. Soriano, A. Aguilera, C. de Mendoza, 2011, The Journal of antimicrobial chemotherapy.

HIV co-infection in HTLV-1 carriers in Spain.

V. Soriano, A. Aguilera, C. de Mendoza, 2019, Virus research.

HTLV-1 infection and disease in Spain.

S. Sauleda, J. Eiros, V. Soriano, 2017, AIDS (London).

Prevalence of HTLV-1/2 infections in Spain: A cross-sectional hospital-based survey.

G. Marcaida, V. Soriano, Araceli Hernández, 2010, AIDS research and human retroviruses.

Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

V. Soriano, C. de Mendoza, R. García-Delgado, 2017, The Journal of antimicrobial chemotherapy.

Dolutegravir, abacavir and lamivudine as HIV therapy

V. Soriano, C. de Mendoza, P. Labarga, 2014, Expert opinion on pharmacotherapy.

Predictors of in-hospital mortality in HIV-infected patients with COVID-19.

M. Martinez-Urbistondo, V. Soriano, C. de Mendoza, 2022, QJM : monthly journal of the Association of Physicians.

Impact of cardiovascular risk factors in antiphospholipid syndrome: an observational study from the Spanish national registry.

G. Ruiz-Irastorza, M. Martinez-Urbistondo, A. Royuela, 2021, Clinical and experimental rheumatology.

Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

E. Poveda, J. Blanco, V. Soriano, 2013, AIDS.

Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort

N. Bannert, A. Sönnerborg, D. Paraskevis, 2017, AIDS.

Mechanisms of resistance to antiretroviral drugs--clinical implications.

V. Soriano, C. de Mendoza, O. Gallego, 2002, AIDS reviews.

Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

V. Soriano, C. de Mendoza, A. Corral, 2003, Journal of Clinical Microbiology.

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

V. Soriano, M. Leal, J. Arribas, 2001, AIDS.

Long-Term Outcome of HIV-Infected Patients with Multinucleoside-Resistant Genotypes

V. Soriano, C. Altisent, C. de Mendoza, 2003, HIV clinical trials.

Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain

V. Soriano, A. Aguilera, C. de Mendoza, 2018, European journal of gastroenterology & hepatology.

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy

V. Soriano, C. de Mendoza, A. Treviño, 2023, Drug design, development and therapy.

Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid.

V. Soriano, J. del Romero, C. de Mendoza, 2002, AIDS.

Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1.

V. Soriano, J. Eiros, J. Torre-Cisneros, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

J. Ramos-Rincón, V. Soriano, C. de Mendoza, 2022, Alimentary pharmacology & therapeutics.

Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies

J. Ramos-Rincón, V. Soriano, F. Gómez-Gallego, 2022, Journal of viral hepatitis.

Prevalence of Transmitted HIV-1 Drug Resistance and the Role of Resistance Algorithms: Data From Seroconverters in the CASCADE Collaboration From 1987 to 2003

D. Pillay, G. Poggensee, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

F. Ceccherini‐Silberstein, R. Kaiser, J. Martinez-Picado, 2015, The Journal of antimicrobial chemotherapy.

Relationship between drug resistance mutations, plasma viremia, and CD4+ T‐cell counts in patients with chronic HIV infection

V. Soriano, C. de Mendoza, A. Corral, 2005, Journal of medical virology.

Treatment response and drug resistance in patients infected with HIV type 1 group O viruses.

B. Rodés, V. Soriano, C. de Mendoza, 2005, AIDS research and human retroviruses.

Impact of Human Immunodeficiency Virus Type 1 (HIV-1) Genetic Diversity on Performance of Four Commercial Viral Load Assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT

V. Soriano, J. Hackett, C. de Mendoza, 2005, Journal of Clinical Microbiology.

Mitochondrial Dna Depletion in HIV-Infected Patients is More Pronounced with Chronic Hepatitis C and Enhanced following Treatment with Pegylated Interferon plus Ribavirin

E. Timmermans, V. Soriano, M. Buitelaar, 2005, Antiviral therapy.

Hydroxyurea plus Didanosine as Maintenance Therapy for HIV-Infected Patients on Long-Term Successful Highly Active Antiretroviral Therapy

V. Soriano, C. de Mendoza, J. González-lahoz, 2003, HIV clinical trials.

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

B. Rodés, V. Soriano, M. Pérez-Olmeda, 1999, Journal of human virology.

Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database

E. Poveda, V. Soriano, E. Seclén, 2010, AIDS.

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.

V. Soriano, L. Menéndez-Arias, C. de Mendoza, 2009, AIDS reviews.

Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.

V. Soriano, J. Hackett, C. de Mendoza, 2012, AIDS research and human retroviruses.

A Highly Sensitive and Specific Model for Predicting HIV-1 Tropism in Treatment-Experienced Patients Combining Interpretation of V3 Loop Sequences and Clinical Parameters

E. Poveda, V. Soriano, C. de Mendoza, 2011, Journal of acquired immune deficiency syndromes.

High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.

E. Poveda, V. Soriano, E. Seclén, 2010, The Journal of antimicrobial chemotherapy.

Resistance associated mutations to dolutegravir (S/GSK1349572) in HIV-infected patients--impact of HIV subtypes and prior raltegravir experience.

V. Soriano, A. Geretti, C. de Mendoza, 2011, Antiviral research.

Impact of baseline protease genotype and phenotype on the response to darunavir outside clinical trials.

E. Poveda, V. Soriano, J. Villacian, 2007, The Journal of antimicrobial chemotherapy.

Safety considerations in the management of hepatitis C and HIV co-infection

V. Soriano, C. de Mendoza, P. Barreiro, 2023, Expert opinion on drug safety.

The slowdown of new infections by human retroviruses has reached a plateau in Spain

M. J. Pozuelo, S. Sauleda, A. Aguilera, 2023, Journal of Medical Virology.

Considerations on HTLV-1 infection in Spain

J. Eiros, V. Soriano, A. Aguilera, 2021, Medicina Clínica (English Edition).

Considerations on HTLV-1 infection in Spain.

J. Eiros, V. Soriano, A. Aguilera, 2020, Medicina clínica (Ed. impresa).

Pre-Exposure Prophylaxis for viral infections other than HIV.

V. Soriano, C. de Mendoza, P. Barreiro, 2022, Le infezioni in medicina.

Late presentation of HTLV-1 infection in Spain reflects suboptimal testing strategies.

V. Soriano, A. Aguilera, M. Fernández-Ruiz, 2022, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain.

J. Eiros, V. Soriano, C. de Mendoza, 2021, AIDS research and human retroviruses.

Phylogenetic reconstruction of transmission events from individuals with acute HIV infection: toward more-rigorous epidemiological definitions.

D. Pillay, B. Masquelier, C. Balotta, 2009, The Journal of infectious diseases.

Failure to detect human immunodeficiency virus type 1 superinfection in 28 HIV-seroconcordant individuals with high risk of reexposure to the virus.

M. Quiñones-Mateu, V. Soriano, C. de Mendoza, 2004, AIDS research and human retroviruses.

Prevalence of the HIV-1 protease mutation I47A in clinical practice and association with lopinavir resistance

L. Bacheler, V. Soriano, T. Pattery, 2006, AIDS.

Molecular Surveillance of HIV-1 in Madrid, Spain: a Phylogeographic Analysis

Á. Holguín, F. González-Candelas, L. Cardeñoso, 2011, Journal of Virology.

Treatment of hepatitis delta and HIV infection

J. Ramos-Rincón, V. Soriano, C. de Mendoza, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Mortality by COVID-19 Before Vaccination - One Year Experience of Hospitalized Patients in Madrid

Y. Tung-Chen, C. de Mendoza, I. Pintos-Pascual, 2022, International Journal of Infectious Diseases.

COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study

M. Martinez-Urbistondo, V. Cuervas-Mons, C. de Mendoza, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

G. Ruiz-Irastorza, M. Martinez-Urbistondo, C. de Mendoza, 2023, Autoimmunity Reviews.

New therapeutic strategies for raltegravir.

V. Soriano, C. de Mendoza, C. Garrido, 2010, The Journal of antimicrobial chemotherapy.

Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS Research and Human Retroviruses.

Superiority of protease inhibitors over nonnucleoside reverse-transcriptase inhibitors when highly active antiretroviral therapy is resumed after treatment interruption.

Pablo Barreiro, V. Soriano, C. de Mendoza, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.

V. Soriano, C. de Mendoza, I. Jiménez-Nácher, 2003, AIDS.

Role of Baseline Human Immunodeficiency Virus Genotype as a Predictor of Viral Response to Tenofovir in Heavily Pretreated Patients

V. Soriano, C. de Mendoza, P. Domingo, 2003, Journal of Clinical Microbiology.

Safety and efficacy of tenofovir/emtricitabine plus nevirapine in HIV-infected patients

E. Poveda, V. Soriano, E. Seclén, 2010, AIDS.

Evidence for different susceptibility to tipranavir and darunavir in patients infected with distinct HIV-1 subtypes

E. Poveda, V. Soriano, N. Parkin, 2008, AIDS.

Tenofovir for Hepatitis Delta

V. Soriano, C. de Mendoza, P. Barreiro, 2016, Hepatology.

Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors.

E. Poveda, V. Soriano, C. de Mendoza, 2007, The Journal of antimicrobial chemotherapy.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus

Anne M Johnson, C. Morrison, P. Vanhems, 2017, The Journal of antimicrobial chemotherapy.

Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients

M. Martinez-Urbistondo, C. de Mendoza, A. Andres, 2021, Journal of clinical medicine.

Higher antiviral activity of antiretroviral regimens including protease inhibitors.

V. Soriano, C. de Mendoza, J. González-lahoz, 1999, AIDS.

HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors

N. Pantazis, N. Bannert, M. Prins, 2019, BMC Medicine.

Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain.

J. Ramos-Rincón, V. Soriano, C. de Mendoza, 2023, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Association between tipranavir plasma levels and virological response in HIV-infected patients.

V. Soriano, C. de Mendoza, S. Rodríguez-Nóvoa, 2008, AIDS research and human retroviruses.

Transmission of HIV type 1 through blood transfusion from an antibody-negative/p24 antigen-negative donor.

B. Rodés, C. Toro, E. Poveda, 2003, AIDS research and human retroviruses.

Susceptibility to hepatitis B virus infection in adults living in Spain

V. Soriano, A. Aguilera, F. Gómez-Gallego, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

V. Soriano, J. Villacian, T. Pattery, 2012, Antimicrobial Agents and Chemotherapy.

HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System

A. Johannessen, C. de Mendoza, N. Zahonero, 2010, The Journal of antimicrobial chemotherapy.

Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir.

V. Soriano, C. de Mendoza, A. Corral, 2002, Clinical Infectious Diseases.

Association Between Submaximal Suppression of HIV Replication and Use of Drug Combinations Without Protease Inhibitors

V. Soriano, C. de Mendoza, J. González-Lahoz, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Changes in drug resistance patterns following the introduction of HIV type 1 non-B subtypes in Spain.

E. Poveda, V. Soriano, C. de Mendoza, 2009, AIDS research and human retroviruses.

Genetic signature detected in T cell receptors from patients with severe COVID-19

T. Korcsmáros, Pedro Seoane, J. Perkins, 2023, iScience.

Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy

E. Poveda, V. Soriano, J. Blanco, 2010, Antimicrobial Agents and Chemotherapy.

Use of Different Inhibitory Quotients To Predict Early Virological Response to Tipranavir in Antiretroviral-Experienced Human Immunodeficiency Virus-Infected Patients

V. Soriano, C. de Mendoza, A. Corral, 2009, Antimicrobial Agents and Chemotherapy.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.

N. Parkin, J. Bremer, R. Schuurman, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

E. Poveda, V. Soriano, C. de Mendoza, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

New antivirals for the treatment of chronic hepatitis B

V. Soriano, J. Peña, C. de Mendoza, 2017, Expert opinion on investigational drugs.

HTLV-1 infection and health outcomes.

V. Soriano, C. de Mendoza, J. Ramos, 2020, The Lancet. Infectious diseases.

Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy.

E. Poveda, V. Soriano, C. de Mendoza, 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Gene therapy for HIV infection

V. Soriano, C. de Mendoza, P. Barreiro, 2015, Expert opinion on biological therapy.

Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

Andrea K. Thoma-Kress, C. de Mendoza, O. Cassar, 2024, NeuroImmune Pharmacology and Therapeutics.

Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors.

E. Poveda, V. Soriano, V. Briz, 2007, The Journal of antimicrobial chemotherapy.

R. San-Cristóbal, L. Daimiel, J. A. Martínez, 2020, Mediators of inflammation.